GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
L

LTR Pharma LTP.AX · AUD

Health Care · ASX · 🇦🇺 Australia

Compare

0.46

+8.33%

Close of 9 Nov 2026, in AUD

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

Price performance

Chart by TradingView, with its own licensed prices

LTR Pharma — daily ASX:LTP

No embeddable chart for this listing. TradingView's free widgets do not cover this exchange, and an unsupported symbol would render an error panel rather than a chart.

View LTR Pharma on TradingView ↗
Market value
A$82.7m
Last close × shares
Volume
56.8k
Shares, 9 Nov 2026

About LTR Pharma

Its shares trade on ASX under the ticker LTP.AX. It has been listed since 11 December 2023. In the fiscal year to 30 June 2026, it reported revenue of A$183,928 and a net loss of A$14.2m. At that date it held total assets of A$20.9m and shareholders' equity of A$20.3m.

LTR Pharma Ltd is a AU-based company operating in Pharmaceuticals industry. The company is headquartered in Brisbane, Queensland. The company went IPO on 2023-12-11. LTR Pharma Limited is an Australia-based clinical-stage biopharmaceutical company. The firm is focused on holistically improving men’s health, physically and mentally, through the commercialization of an intranasal spray treatment for Erectile Dysfunction (ED). Its lead product SPONTAN is set apart from existing ED therapies by its mechanism of action-intranasal delivery technology of a PDE5 inhibitor. The nasal cavity is a highly vascular part of the body supporting even and rapid absorption of the drug, empowering it to work in 10 minutes or less. SPONTAN (SDS-089) is a novel intranasal drug (PDE5) delivery platform for Erectile Dysfunction.

Figures and description from our data supplier, not checked against the company's own report.

More about LTR Pharma →

Latest on LTR Pharma

Our reporting

We have not reported on LTR Pharma yet.

Other Health Care listings

Scenario calculator

Try your own numbers. This is arithmetic, not a forecast.

Interactive

Gain or loss

—

Return

—

Leaves out fees, taxes and financing.

Frequently asked questions

What is LTR Pharma's ticker?

LTR Pharma trades as LTP.AX on ASX, under ISIN AU0000305294.

What was LTR Pharma's last closing price?

0.46 on 9 Nov 2026. The figure is in AUD and is never converted.

Sources and methodology

Chart
TradingView
Close and company data
Our data supplier
News
Our reporting

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.